Table 3

Evolution of the HFMS scores in the two SMA groups (type II and III) during the VPA treatment.

Evaluations


SMA

1

2

3

4

5

p (*)


Type II

13.6 ± 10.0

14.9 ± 11.4

15.5 ± 11.1

16.0 ± 11.2

16.9 ± 10.6

0.031

Type III

24.9 ± 3.4

24.8 ± 3.3

24.4 ± 3.5

24.4 ± 3.5

24.1 ± 3.9

0.961

p (**)

0.006

0.016

0.029

0.039

0.051


* Comparison between the first evaluation with the subsequent ones

** Comparison between both groups (type II and III) in each evaluation

Darbar et al. BMC Neurology 2011 11:36   doi:10.1186/1471-2377-11-36

Open Data